Volume 19, Issue 4 pp. 623-629
Free to Read

Interphase Cytogenetics for 1p19q and t(1;19)(q10;p10) may Distinguish Prognostically Relevant Subgroups in Extraventricular Neurocytoma

Fausto J. Rodriguez

Corresponding Author

Fausto J. Rodriguez

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Fausto J. Rodriguez, MD, Mayo Clinic College of Medicine , 200 First Street SW, Mayo Clinic, Rochester, MN 55905 (Email: [email protected])Search for more papers by this author
Renan A. Mota

Renan A. Mota

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Search for more papers by this author
Bernd W. Scheithauer

Bernd W. Scheithauer

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Search for more papers by this author
Caterina Giannini

Caterina Giannini

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Search for more papers by this author
Hilary Blair

Hilary Blair

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Search for more papers by this author
Kent C. New

Kent C. New

Neurosurgery, Mayo Clinic, Jacksonville, Fla.

Search for more papers by this author
Kevin J. Wu

Kevin J. Wu

Departments of Pathology and

Search for more papers by this author
Dennis W. Dickson

Dennis W. Dickson

Departments of Pathology and

Search for more papers by this author
Robert B. Jenkins

Robert B. Jenkins

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Search for more papers by this author
First published: 04 September 2009
Citations: 50

Abstract

Co-deletion of chromosome arms 1p and 19q, characteristic of oligodendroglial tumors, was recently found to be mediated by t(1;19)(q10;p10). To evaluate the prevalence of 1p19q co-deletion and t(1;19) in extraventricular neurocytomas (EVN), we studied tumors from 23 patients, including 13 females and 10 males (median age at diagnosis 34 years, range 2–76 years). Fluorescence in situ hybridization (FISH) studies were performed with probes targeting 1p36/1q25 and 19q13/19p13 to assess for 1p19q co-deletion, as well as chromosome 1 α-satellite and 19p12 to detect t(1;19)(q10;p10). FISH was successful in 21 (91%) cases and demonstrated 1p19q co-deletion in five cases (24%) or isolated 1p loss in two cases (10%). Evidence for t(1;19) was found in four (of five) cases with 1p19q co-deletion. Three tumors with 1p19q loss and t(1;19) demonstrated atypical histologic features, compared with one (of 17) tumors without 1p19q co-deletion (P = 0.01, Fisher exact test). In addition, tumors with t(1;19) showed increased mitotic activity compared with tumors without t(1;19) (P = 0.045; Wilcoxon rank sum test). The four patients with t(1;19) developed tumor recurrence (n = 3), or expired (n = 2) 3.5 to 5.5 years after first resection. These results suggest that 1p19q loss and t(1;19) occur in a subset of EVN, and may be associated with aggressive histology in these tumors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.